Why do you not use Steroids?
09-02-2017, 07:47 PM
''Oral anabolic steroids are no more hard on your body than tylenol.''- helmutschmidt31
Neri M, Bello S, Bonsignore A, et al. Anabolic androgenic steroids abuse and liver toxicity. Mine Rev Med Chem. 2011;11(5):430–437
Gorayski P, Thompson CH, Subhash HS, Thomas AC. Hepatocellular carcinoma associated with recreational anabolic steroid use. Br J Sports Med. 2008;42(1):74–75; discussion 75.
POPE HG JR, WOOD RI, ROGOL A, NYBERG F, BOWERS
L, BHASIN S. Adverse health consequences of performance-enhancing
drugs: an endocrine society
scientific statement. Endocr Rev 2014; 35: 341-
375.
QUAGLIO G, FORNASIERO A, MEZZELANI P, MORESCHINI
S, LUGOBONI F, LECHI A. Anabolic steroids: dependence
and complications of chronic use. Intern
Emerg Med 2009; 4: 289-296
FRATI P, BUSARDÒ FP, CIPOLLONI L, DOMINICIS ED,
FINESCHI V. Anabolic Androgenic Steroid (AAS) related
deaths: autoptic, histopathological and toxicological
findings. Curr Neuropharmacol 2015; 13:
146-159.
BÜTTNER A,THIEME D. Side effects of anabolic androgenic
steroids: pathological findings and structure-activity
relationships. Handb Exp Pharmacol
2010; 195: 459-484.
NIESCHLAG E, VORONA E. Doping with anabolic androgenic
steroids (AAS): adverse effects on nonreproductive
organs and functions. Rev Endocr
Metab Disord 2015; 16: 199-211
SOCAS L, ZUMBADO M, PÉREZ-LUZARDO O, RAMOS A,
PÉREZ C, HERNÁNDEZ JR, BOADA LD. Hepatocellular
adenomas associated with anabolic androgenic
steroid abuse in bodybuilders: a report of two cases
and a review of the literature. Br J Sports Med
2005; 39: e27
BOND P, LLEWELLYN W, VAN MOL P. Anabolic androgenic
steroid-induced hepatotoxicity. Med Hypotheses
2016; 93: 150-153.
MODLINSKI R, FIELDS KB. The effect of anabolic
steroids on the gastrointestinal system, kidneys,
and adrenal glands. Curr Sports Med Rep 2006;
5: 104-109.
ROBLES-DIAZ M, GONZALEZ-JIMENEZ A, MEDINA-CALIZ I,
STEPHENS C, GARCÍA-CORTES M, GARCÍA-MUÑOZ B, ORTEGA-ALONSO
A, BLANCO-REINA E, GONZALEZ-GRANDE
R, JIMENEZ-PEREZ M, RENDÓN P, NAVARRO JM, GINES P,
PRIETO M, GARCIA-ELIZ M, BESSONE F, BRAHM JR,
PARANÁ R, LUCENA MI, ANDRADE RJ; SPANISH DILI REGISTRY;
SLATINDILI NETWORK. Distinct phenotype of hepatotoxicity
associated with illicit use of anabolic
androgenic steroids. Aliment Pharmacol Ther
2015; 41: 116-125.
GIANNITRAPANI L, SORESI M, LA SPADA E, CERVELLO M,
D'ALESSANDRO N, MONTALTO G. Sex hormones and
risk of liver tumor. Ann N Y Acad Sci 2006; 1089:
228-236.
Many cardiac effects as well (like tylenol lol?).
Far HR, Ågren G, Thiblin I. Cardiac hypertrophy in deceased users of anabolic androgenic steroids: an investigation of autopsy findings. Cardiovasc Pathol. 2012;21(4):312–316.
Sculthorpe N, Grace F, Jones P, Davies B. Evidence of altered cardiac electrophysiology following prolonged androgenic anabolic steroid use. Cardiovasc Toxicol. 2010;10(4):239–243.
Maior AS, Carvalho AR, Marques-Neto SR, Menezes P, Soares PP, Nascimento JH. Cardiac autonomic dysfunction in anabolic steroid users. Scand J Med Sci Sports. 2013;23(5):548–555.
Montisci R, Cecchetto G, Ruscazio M, et al. Early myocardial dysfunction after chronic use of anabolic androgenic steroids: combined pulsed-wave tissue Doppler imaging and ultrasonic integrated backscatter cyclic variations analysis. J Am Soc Echocardiogr. 2010;23(5):516–522.
Baggish AL, Weiner RB, Kanayama G, et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circulation. 2010;3:472–476